Diagnosis of Acromegaly: Black, White… and Sometimes Gray!

Overview

Journal Arch Endocrinol Metab

Specialty Endocrinology

Date 2016 Dec 17

PMID 27982196

Authors

Philippe Chanson

Affiliations

Soon will be listed here.

References

Chanson P, Arnoux A, Mavromati M, Brailly-Tabard S, Massart C, Young J . Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays. J Clin Endocrinol Metab. 2016; 101(9):3450-8. PMC: 5054194. DOI: 10.1210/jc.2016-1257. View

Ribeiro-Oliveira Jr A, Barkan A . The changing face of acromegaly--advances in diagnosis and treatment. Nat Rev Endocrinol. 2012; 8(10):605-11. DOI: 10.1038/nrendo.2012.101. View

Katznelson L, Laws Jr E, Melmed S, Molitch M, Murad M, Utz A . Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014; 99(11):3933-51. DOI: 10.1210/jc.2014-2700. View

Ribeiro-Oliveira Jr A, Faje A, Barkan A . Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol. 2010; 164(1):17-22. DOI: 10.1530/EJE-10-0744. View

Clemmons D . Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem. 2011; 57(4):555-9. DOI: 10.1373/clinchem.2010.150631. View

Juul A . Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003; 13(4):113-70. DOI: 10.1016/s1096-6374(03)00038-8. View

Ribeiro-Oliveira Jr A, Faje A, Barkan A . Postglucose growth hormone nadir and insulin-like growth factor-1 in naïve-active acromegalic patients: do these parameters always correlate?. Arq Bras Endocrinol Metabol. 2011; 55(7):494-7. DOI: 10.1590/s0004-27302011000700011. View

Dimaraki E, Jaffe C, Chandler W, Barkan A . Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab. 2002; 87(8):3537-42. DOI: 10.1210/jcem.87.8.8658. View

Chanson P, Salenave S, Kamenicky P . Acromegaly. Handb Clin Neurol. 2014; 124:197-219. DOI: 10.1016/B978-0-444-59602-4.00014-9. View

10.

Frystyk J, Freda P, Clemmons D . The current status of IGF-I assays--a 2009 update. Growth Horm IGF Res. 2009; 20(1):8-18. PMC: 7748085. DOI: 10.1016/j.ghir.2009.09.004. View

11.

Leung K, Johannsson G, Leong G, Ho K . Estrogen regulation of growth hormone action. Endocr Rev. 2004; 25(5):693-721. DOI: 10.1210/er.2003-0035. View

12.

Arafat A, Mohlig M, Weickert M, Perschel F, Purschwitz J, Spranger J . Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab. 2008; 93(4):1254-62. DOI: 10.1210/jc.2007-2084. View

13.

Borofsky N, Vogelman J, Krajcik R, Orentreich N . Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. Clin Chem. 2002; 48(12):2248-51. View

14.

Carmichael J, Bonert V, Mirocha J, Melmed S . The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab. 2008; 94(2):523-7. DOI: 10.1210/jc.2008-1371. View

15.

Clemmons D . Value of insulin-like growth factor system markers in the assessment of growth hormone status. Endocrinol Metab Clin North Am. 2007; 36(1):109-29. DOI: 10.1016/j.ecl.2006.11.008. View

16.

Meinhardt U, Ho K . Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf). 2006; 65(4):413-22. DOI: 10.1111/j.1365-2265.2006.02676.x. View

17.

Subbarayan S, Fleseriu M, Gordon M, Brzana J, Kennedy L, Faiman C . Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated IGF-1 but normal glucose-suppressed growth hormone. Endocr Pract. 2012; 18(6):817-25. DOI: 10.4158/EP11324.OR. View

18.

Simpkin A, Schwartzstein R . Tolerating Uncertainty - The Next Medical Revolution?. N Engl J Med. 2016; 375(18):1713-1715. DOI: 10.1056/NEJMp1606402. View

19.

Rosario P, Calsolari M . Elevated IGF-1 with GH suppression after an oral glucose overload: incipient acromegaly or false-positive IGF-1?. Arch Endocrinol Metab. 2016; 60(6):510-514. PMC: 10522166. DOI: 10.1590/2359-3997000000193. View

20.

Freda P, Reyes C, Nuruzzaman A, Sundeen R, Bruce J . Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly. Pituitary. 2004; 6(4):175-80. DOI: 10.1023/b:pitu.0000023424.72021.e2. View